※Please note that the actual color of the product may appear slightly different depending on your device setting.
※The above crude drug photos are for illustrative purposes only.

Tsumura-Kampo Hangeshashinto Extract Granules

Category 2 OTC medicines

PRODUCT INFORMATION

INDICATIONS

Following symptoms in persons with moderate physical strengthwho have difficulty in swallowing at the solar plexus and a tendency to soft stools or diarrhea and sometimes experience nausea, vomiting, stomach growling and loss of appetite: Acute or chronic gastroenteritis, diarrhea/soft stools, dyspepsia, gastroptosis, neurological gastritis, stomach weakness, hangover, belching, heartburn, and stomatitis, neurosis.

INGREDIENTS

2 packets (3.75 g) of this medicine contain 2.25 g of Hangeshashinto extract of the following mixed crude drugs;

JP Pinellia Tuber 2.5 g
JP Scutellaria Root 1.25 g
JP Processed Ginger 1.25 g
JP Glycyrrhiza 1.25 g
JP Jujube 1.25 g
JP Ginseng 1.25 g
JP Coptis Rhizome 0.5 g

(JP: The Japanese Pharmacopoeia)
Inactive ingredients: JP Magnesium Stearate, JP Lactose Hydrate, Sucrose Esters of Fatty Acids

DOSAGE

Take the following dosages with water or warm water before a meal.

Age One dosage Daily dosage
15 years and over 1 packet(1.875 g) 2 times a day
7-14 years 2/3 packet
4-6 years 1/2 packet
2-3 years 1/3 packet
Under 2 years Do not use

[Cautions] This medication should be given to children only under adult supervision

PRECAUTIONS FOR HANDLING

PRECAUTIONS FOR STRAGE AND HANDLING

  1. Store in a cool, dry place free from direct sunlight.

  2. Keep all medication out of the reach of children.

  3. When you take this medicine in divided dose, fold over the opened edge of the packet and store it. The remaining medicine should be taken within 2 days.

  4. Since the medicine contains crude drugs, the granules color may vary for individual products, however this has no influence on the efficacy of this medicine.

  5. Do not take this medicine after the expiration date.

CAUTION FOR USE

Who should seek consultation

  1. The following persons should consult a physician, pharmacist, or registered distributor before taking this medicine.

    1. Persons undergoing medical treatment from a physician.
    2. Pregnant women or women suspected of being pregnant.
    3. Elderly persons.
    4. Persons who have experienced rash, redness, itching, etc. due to medicines or something.
    5. Persons with the following symptoms: edema.
    6. Persons diagnosed as having the following: hypertension, heart disease, kidney disease.
  2. The following symptoms may be adverse reactions to this medication. If any of these symptoms occur, stop taking this medicine immediately and consult a physician, pharmacist, or registered distributor. Take the instraction leaflet with you.

    Related areas Symptoms
    Skin

    Rash, redness, itching

    In very rare cases the following serious symptoms may occur. In this case, consult a physician immediately.

    Symptoms' name Symptoms
    Interstitial pneumonia

    When go upstairs or exert yourself too much, symptoms such as shortness of breath, breathing difficulties, dry cough, and fever will appear. They will appear suddenly and persist.

    Pseudoaldosteronism, myopathy

    In addition to listlessness, stretched feeling, and stiffness of hands and feet, feeling of weakness and muscular pain will appear and gradually worsen.

    Hepatic function failure

    Following symptoms appear: fever, itching, rash, jaundice (yellowing of skin and white of eyes), brown urine, whole-body tiredness, loss of appetite.

  3. Stop taking this medicine and consult a physician, pharmacist or registered distributor if symptoms do not improve after taking this medicine for about 1 month ( 5 or 6 times if you take this medicine for gastroenteritis, hangover, belching or heartburn). Take this leaflet with you.

  4. If you take this medicine regularly for a long periods, consult a physician, pharmacist or registered distributor.

Production of this product has been approved for domestic sales in accordance with the Pharmaceutical Affairs Law of Japan.